Ignite Creation Date:
2025-12-25 @ 2:00 AM
Ignite Modification Date:
2026-02-25 @ 5:52 PM
Study NCT ID:
NCT02605694
Status:
WITHDRAWN
Last Update Posted:
2021-03-17
First Post:
2015-11-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Duvelisib With Rituximab vs R-CHOP in Subjects With Relapsed/Refractory Follicular Lymphoma (FRESCO)
Sponsor:
SecuraBio
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-12
Start Date Type:
None
Primary Completion Date:
2016-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-11
Completion Date Type:
ACTUAL
First Submit Date:
2015-11-04
First Submit QC Date:
None
Study First Post Date:
2015-11-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-03-15
Last Update Post Date:
2021-03-17
Last Update Post Date Type:
ACTUAL